MedPath

Bioavailability of Fatty Acids From Krill Oil and Krill Meal and Fatty Acids From Fish Oil in Healthy Subjects.

Phase 2
Completed
Conditions
Healthy
Interventions
Dietary Supplement: Krill oil
Dietary Supplement: Krill meal
Dietary Supplement: Fish oil
Registration Number
NCT02089165
Lead Sponsor
Olympic Seafood AS
Brief Summary

The purpose of the study is to compare the acute bioavailability of two different krill oil products called krill oil and krill meal in comparison to fish oil product.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
19
Inclusion Criteria
  • Healthy female and male
  • Age 18 - 65 years
  • Body mass index 18.5 - 30
  • Informed consent, signed
Exclusion Criteria
  • Medication potential to affect the bioavailability of fatty acids (e.g. lipid-lowering drugs)
  • Familial hypercholesterolemia, marked combined hyperlipidemia, condition that would impair, fat absorption (e.g. chronic pancreatitis, pancreatic lipase deficiency syndrome)
  • Any untreated medical condition affecting absorption of fat
  • Type 1 and 2 diabetes
  • Cancer or other malignant disease within past five years
  • Periodical hormone replacement therapy
  • High intake of oily fish (once a week or more) (i.e. salmon, herring, sardines, mackerel, vendace)
  • Smoking
  • Alcohol consumption > 15 doses per week
  • Females who are pregnant, breast-feeding or intend to become pregnant
  • Hypersensitivity to any of the components of the test product
  • Regular use of n-3 supplements 4 weeks before randomization
  • Lack of suitability for participation in the trial, for any medical reason, as judged by the principal investigator

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Krill oilKrill oilThe interventions are administered in the randomized order.
Krill mealKrill mealThe interventions are administered in the randomized order.
Fish oilFish oilThe interventions are administered in the randomized order.
Primary Outcome Measures
NameTimeMethod
Incremental 0-72 h area under the curve of EPA + DHA proportion in plasma phospholipids.0-72 h
Secondary Outcome Measures
NameTimeMethod
Incremental 0-72 h area under the curve of EPA + DHA proportion in plasma triglyceride.0-72 h

Trial Locations

Locations (1)

Oy Foodfiles Ltd, memeber of Foodfiles group

🇫🇮

Kuopio, Finland

© Copyright 2025. All Rights Reserved by MedPath